Pulmonx Corp (LUNG) has 116 open-market insider trades by 16 insiders since 2020. Over the last six months insiders net sold $321K. The most active filer is Geoffrey Beran Rose, CCO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Boston Scientific Corp. | 10% Owner | — | 3 | $232.1M | 2021-07-13 |
| Glendon E. French III | CEOPres | — | 28 | $13.3M | 2026-09-01 |
| Geoffrey Beran Rose | CCO | — | 31 | $3.2M | 2026-09-01 |
| Derrick Sung | CFO | — | 12 | $1.0M | 2025-12-01 |
| Daniel P. Florin | Dir | — | 4 | $641K | 2026-06-05 |
| Steven S. Williamson | CEOPres | — | 4 | $637K | 2025-09-02 |
| David Aaron Lehman | CLO | — | 20 | $506K | 2026-09-01 |
| Dana G. Mead Jr. | Dir | — | 1 | $500K | 2026-06-05 |
| Georgia Melenikiotou | Dir | — | 1 | $500K | 2026-06-05 |
| Richard M. Ferrari | Dir | — | 1 | $250K | 2021-06-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Aaron Lehman | CLO | Sell | $32K | 2026-09-01 |
| Glendon E. French III | CEO & President | Sell | $95K | 2026-09-01 |
| Geoffrey Beran Rose | CCO | Sell | $18K | 2026-09-01 |
| Srikanth Radhakrishnan | — | Sell | $32K | 2026-09-01 |
| Geoffrey Beran Rose | CCO | Sell | $12K | 2026-06-01 |
| David Aaron Lehman | CLO | Sell | $22K | 2026-06-01 |
Companies that share insiders with LUNG, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Srikanth Radhakrishnan | — | Sell | $22K | 2026-06-01 |
| Glendon E. French III | CEO & President | Sell | $87K | 2026-06-01 |
| Srikanth Radhakrishnan | — | Sell | $15K | 2026-03-02 |
| Glendon E. French III | President | Sell | $97K | 2026-03-02 |
| Geoffrey Beran Rose | CCO | Sell | $11K | 2026-03-02 |
| David Aaron Lehman | CLO | Sell | $17K | 2026-03-02 |
| Daniel P. Florin | Director | Sell | $46K | 2025-12-08 |
| David Aaron Lehman | GENERAL COUNSEL | Sell | $16K | 2025-12-01 |
| Geoffrey Beran Rose | CHIEF COMMERCIAL OFFICER | Sell | $10K | 2025-12-01 |